Topline Results of Food Effect Study of the Product Candidate Estelle®, the new combined oral contraceptive composed of 15mg of Estetrol (E4) and 3mg of Drospirenone (DRSP)

Liège, Belgium 01 April 2016 –  Mithra announces the results of the Food Effect Study of the product candidate Estelle. The study demonstrated that the concomitant food intake with a single dose of Estelle in women resulted in a decrease for Estetrol and Drospirerone rate of absorption (Cmax) while the extent of exposure (AUC) of both Estetrol and Drospirenone was not impacted. This was the result that Mithra wanted to obtain from the study.

Read the press release